MedTrace Logo

Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients

NCT01981083 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-11-11

No results posted yet for this study

Summary

Malnutrition is seen frequently in hemodialysis units in most developing countries. Malnutrition increases morbidity and mortality in this population and its treatment improves patient survival and health status The purpose of this study is to compare two strategies to improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml) versus egg albumin-based protein supplement (30 g) on a daily basis.

This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment (SGA) in addition to most used biochemical markers to determine nutritional status.

Conditions

  • Protein-Energy Malnutrition
  • Kidney Failure, Chronic
  • Hemodialysis

Interventions

DIETARY_SUPPLEMENT

Egg albumin-based protein supplement

DIETARY_SUPPLEMENT

Renal-specific oral supplement

Sponsors & Collaborators

  • Centro Medico Lic Adolfo Lopez Mate

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-11-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01981083 on ClinicalTrials.gov